References: |
JNK Inhibitor IX (TCS-JNK-5a) is a thienylnaphthamide compound that targets the ATP binding site of JNK2 and JNK3, disrupting activity with pIC50 values of 6.5 and 6.7, respectively.It demonstrates little activity against JNK1, p38α, and a panel of more than 30 other kinases (pIC50 < 5.0). For the detailed information of TCS JNK 5a(JNK Inhibitor IX), the solubility of TCS JNK 5a(JNK Inhibitor IX) in water, the solubility of TCS JNK 5a(JNK Inhibitor IX) in DMSO, the solubility of TCS JNK 5a(JNK Inhibitor IX) in PBS buffer, the animal experiment (test) of TCS JNK 5a(JNK Inhibitor IX), the cell expriment (test) of TCS JNK 5a(JNK Inhibitor IX), the in vivo, in vitro and clinical trial test of TCS JNK 5a(JNK Inhibitor IX), the EC50, IC50,and affinity,of TCS JNK 5a(JNK Inhibitor IX), For the detailed information of TCS JNK 5a(JNK Inhibitor IX), the solubility of TCS JNK 5a(JNK Inhibitor IX) in water, the solubility of TCS JNK 5a(JNK Inhibitor IX) in DMSO, the solubility of TCS JNK 5a(JNK Inhibitor IX) in PBS buffer, the animal experiment (test) of TCS JNK 5a(JNK Inhibitor IX), the cell expriment (test) of TCS JNK 5a(JNK Inhibitor IX), the in vivo, in vitro and clinical trial test of TCS JNK 5a(JNK Inhibitor IX), the EC50, IC50,and affinity,of TCS JNK 5a(JNK Inhibitor IX), Please contact DC Chemicals. |